ONCOSEC MED INC's ticker is ONCSXXXX and the CUSIP is 68234L207. A total of 21 filers reported holding ONCOSEC MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $19,000 | -13.6% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $22,000 | -55.1% | 35,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $49,000 | +2.1% | 35,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $48,000 | -28.4% | 35,000 | -1.5% | 0.00% | -33.3% |
| Q1 2018 | $67,000 | +15.5% | 35,550 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $58,000 | +65.7% | 35,550 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $35,000 | -18.6% | 35,550 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $43,000 | – | 35,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 2,064,297 | $3,881,000 | 0.64% |
| Avoro Capital Advisors LLC | 4,007,696 | $7,534,000 | 0.36% |
| Crestline Management, LP | 201,860 | $379,000 | 0.05% |
| Point72 Asset Management, L.P. | 3,215,000 | $6,044,000 | 0.02% |
| Sofinnova Investments, Inc. | 66,965 | $126,000 | 0.02% |
| FNY Managed Accounts LLC | 10,000 | $18,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 269,432 | $507,000,000 | 0.01% |
| DRW Securities, LLC | 70,000 | $132,000 | 0.01% |
| Perceptive Advisors | 50,000 | $94,000 | 0.00% |
| Cable Hill Partners, LLC | 4,000 | $8,000 | 0.00% |